Key facts
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 29 Jun 2022, 17:10.
Athanasios Skarpelos - 27 Jun 2022 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Reporting relationship
- Director
- Issuer ticker
- AVXL
- Reported as of
- 27 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jun 2022, 17:10:20 UTC
- Prior SEC filing
- 27 May 2022
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/Athanasios Skarpelos
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 29 Jun 2022.
Change
- Previous filing in this sequence was filed on 27 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $10.09
* marks a reported price that did not pass the local price check.